Product Information
LITHIUM CARBONATE 300 MG CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0953 per EA under NDC 62332001431. Its NADAC has been published 421 times since Aug 1, 2018.
FDA first approved this application on Jan 12, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332001431
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA079159FDA Approved
1/12/2009
TE Code
AB
On Market Since
12/27/2016
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 300 MG CAP has been published 421 times since Aug 1, 2018, and over the history we have for it it has risen 107.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0953 per EA |
|---|---|
| All-time high | $0.1240 (Mar 13, 2024) |
| All-time low | $0.0458 (Nov 20, 2019) |
| 52-week high | $0.1151 |
| 52-week low | $0.0926 |
| Median price | $0.0516 |
| Average price | $0.0699 |
| Largest weekly change | +43.9% (Aug 23, 2023) |
| Weeks tracked | 421 |
| Tracking since | Aug 1, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 300 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 300 MG CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.0953 per EA (NDC 62332001431), effective Aug 19, 2026.
How has the price of LITHIUM CARBONATE 300 MG CAP changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 300 MG CAP has risen 107.4%. It has been tracked across 421 weekly CMS publications since Aug 1, 2018.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 300 MG CAP?
Since Aug 1, 2018, the NADAC for LITHIUM CARBONATE 300 MG CAP has ranged from a low of $0.0458 (Nov 20, 2019) to a high of $0.1240 (Mar 13, 2024), with a median of $0.0516 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 300 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LITHIUM CARBONATE 300 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures LITHIUM CARBONATE 300 MG CAP?
LITHIUM CARBONATE 300 MG CAP (NDC 62332001431) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.